Deriu Chiara, Thakur Shaila, Tammaro Olimpia, Fabris Laura
Department of Applied Science and Technology, Politecnico di Torino 10129 Turin Italy
Department of Materials Science and Engineering, Rutgers University Piscataway NJ 08854 USA.
Nanoscale Adv. 2023 Mar 22;5(8):2132-2166. doi: 10.1039/d2na00930g. eCollection 2023 Apr 11.
In the wake of a global, heightened interest towards biomarker and disease detection prompted by the SARS-CoV-2 pandemic, surface enhanced Raman spectroscopy (SERS) positions itself again at the forefront of biosensing innovation. But is it ready to move from the laboratory to the clinic? This review presents the challenges associated with the application of SERS to the biomedical field, and thus, to the use of excitation sources in the near infrared, where allow for cell and through-tissue measurements. Two main tackling strategies will be discussed: (1) acting on the design of the enhancing substrate, which includes manipulation of nanoparticle shape, material, and supramolecular architecture, and (2) acting on the spectral collection set-up. A final perspective highlights the upcoming scientific and technological bets that need to be won in order for SERS to stably transition from benchtop to bedside.
在SARS-CoV-2大流行引发全球对生物标志物和疾病检测的高度关注之后,表面增强拉曼光谱(SERS)再次站在了生物传感创新的前沿。但它准备好从实验室走向临床了吗?这篇综述介绍了将SERS应用于生物医学领域所面临的挑战,以及在近红外区域使用激发源的挑战,近红外激发源可实现细胞和组织穿透测量。将讨论两种主要的应对策略:(1)对增强基底的设计进行改进,包括对纳米颗粒形状、材料和超分子结构的操控;(2)对光谱采集装置进行改进。最后的展望强调了为使SERS从实验室稳定过渡到床边而需要赢得的即将到来的科学和技术赌注。